Plasma protein binding of alpidem in healthy volunteers, in neonates and in liver or renal insufficiency

[1]  E. Perucca,et al.  Altered serum protein binding of carbamazepine in disease states associated with an increasedα1-acid glycoprotein concentration , 2004, European Journal of Clinical Pharmacology.

[2]  G. Bianchetti,et al.  Plasma protein binding of zolpidem in liver and renal insufficiency. , 1988, International journal of clinical pharmacology, therapy, and toxicology.

[3]  F. Belpaire,et al.  Alpha 1-acid glycoprotein concentration and molecular heterogeneity: relationship to oxprenolol binding in serum from healthy volunteers and patients with lung carcinoma or cirrhosis. , 1988, British journal of clinical pharmacology.

[4]  P. Morselli,et al.  Clinical studies with the new anxiolytic alpidem in anxious patients: An overview of the European experiences , 1988, Pharmacology Biochemistry and Behavior.

[5]  S. Z. Langer,et al.  Imidazopyridines as a tool for the characterization of benzodiazepine receptors: A proposal for a pharmacological classification as omega receptor subtypes , 1988, Pharmacology Biochemistry and Behavior.

[6]  H. Curran,et al.  The effects of single doses of alpidem and lorazepam on memory and psychomotor performance in normal humans , 1987, Journal of psychopharmacology.

[7]  M. Carrai,et al.  Effects of development, aging, and renal and hepatic insufficiency as well as hemodialysis on the plasma concentrations of albumin and alpha 1-acid glycoprotein: implications for binding of drugs. , 1986, Therapeutic drug monitoring.

[8]  R. Woosley,et al.  Clinical Pharmacokinetics of Disopyramide , 1986, Clinical pharmacokinetics.

[9]  D. Shand α1-Acid Glycoprotein and Plasma Lidocaine Binding , 1984 .

[10]  D. Shand alpha 1-Acid glycoprotein and plasma lidocaine binding. , 1984, Clinical pharmacokinetics.

[11]  P. Morselli,et al.  Clinical Pharmacokinetics in Newborns and Infants , 1980 .

[12]  K. Piafsky Disease-induced Changes in the Plasma Binding of Basic Drugs , 1980, Clinical pharmacokinetics.

[13]  P. Morselli,et al.  Clinical pharmacokinetics in newborns and infants. Age-related differences and therapeutic implications. , 1980, Clinical pharmacokinetics.

[14]  J. Tillement,et al.  Diseases and Drug Protein Binding , 1978, Clinical pharmacokinetics.

[15]  T. Blaschke Protein Binding and Kinetics of Drugs in Liver Diseases , 1977, Clinical pharmacokinetics.

[16]  J. Heremans,et al.  Immunochemical quantitation of antigens by single radial immunodiffusion. , 1965, Immunochemistry.

[17]  O. H. Lowry,et al.  Protein measurement with the Folin phenol reagent. , 1951, The Journal of biological chemistry.